ngs Latest News

CHI's Commercialization NGS Data and the Cloud Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at The Moscone North Convention Center in San Francisco.

Now Available on www.Bio-ITWorld.com: Don't miss this Complimentary Whitepaper sponsored by EMC

Now Available on www.Bio-ITWorld.com: Don't miss this Complimentary Whitepaper sponsored by RAID Inc.

A 2-day Symposium on "Cloud Computing: Applications and Advances in Life Sciences R&D" will take place on Feb. 19-20, 2012 at the InterContinental Hotel, San Francisco. This symposium is part of many offerings at the Molecular Med TRI-CON 2012.

CHI's Commercialization NGS Data and the Cloud Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at The Moscone North Convention Center in San Francisco.

Now Available on www.Bio-ITWorld.com: Don't miss this Complimentary Whitepaper sponsored by EMC

Now Available on www.Bio-ITWorld.com: Don't miss this Complimentary Whitepaper sponsored by RAID Inc.

IDT’s DECODED newsletter highlights developments in Foundation Medicine’s NGS tumor assay using individually synthesized capture probes

Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc.

Cambridge Healthtech Institute (CHI) will host this 3 hour short course prior to the start of its Innovative Tissue-Based Diagnostics: Decoding Cancer & Other Maladies conference.

BioDatomics is a software/hardware platform supported by cutting edge data storage & delivery technologies and can deliver all the computational power required for high throughput techniques in the discovery of disease treatment, origin & prevention.

A 2-day Symposium on "Cloud Computing: Applications and Advances in Life Sciences R&D" will take place on Feb. 19-20, 2012 at the InterContinental Hotel, San Francisco. This symposium is part of many offerings at the Molecular Med TRI-CON 2012.

Next Generation Sequencing Generates Momentum: Markets Respond to Technology and Innovation Advances Report, Authored by Ken Rubenstein, PhD.

Global Information Inc. would like to present a new market research report, “Next Generation Sequencing Generates Momentum: Markets Respond to Technology and Innovation Advances” published by Insight Pharma Reports.

WiTech, a leading solutions & services company active in the NGN/NGS scenario, today announced they have released the WROP|AAA, an authentication, authorization and accounting system built around a fully-compliant RADIUS server.

New analysis from Frost & Sullivan finds that the market for Next Generation Sequencing earned revenues of $746 million in 2010 and estimates this to reach $3 billion by 2017 worldwide.

Next-Generation Sequencing Spurs Personalized Mitochondrial Medicine Interview Transcript Now Available for Complimentary Download

Cambridge Healthtech Institute (CHI) releases its latest Insight Pharma Report, Next-Generation Sequencing Technologies: Applications and Markets, available at InsightPharmaReports.com

Bioo Scientific launched the AIR™ Small RNA Sequencing Kit for sequencing small RNA using the Illumina platform.

Next-Generation Sequencing (NGS) technologies are not only beginning to supplant traditional Sanger sequencing methodology but are also giving DNA microarrays a run for the money as well, reports Genetic Engineering & Biotechnology News (GEN)